Trinity compound research profile
Adamax
'Adamax' is not a scientifically recognized name — it's a name made up by the companies that sell it, not something that appears in real published...
Research overview
'Adamax' is not a scientifically recognized name — it's a name made up by the companies that sell it, not something that appears in real published research. It's marketed as a modified version of another peptide called Semax, with an extra chemical piece (called an adamantane group) attached to help it last longer and get into the brain more easily. There's no confirmed chemical structure for it in the scientific literature, which means no one can independently verify exactly what's being sold under this name.
Mechanism under study
Since there's no real research on Adamax itself, anything said about what it does is borrowed from its supposed parent compound, Semax, which is thought to raise levels of a brain-growth chemical called BDNF (brain-derived neurotrophic factor) and help brain cells communicate and adapt after stress or injury. Whether Adamax actually does any of this in a similar way has never been tested.
Human evidence summary
None exist. A search of the medical research database PubMed for 'Adamax peptide' turns up zero controlled studies in humans or animals. There are no clinical trials and no measurements of how it behaves in the body. Everything people report about mood, focus, or thinking ability is personal opinion, not science.
Preclinical evidence summary
There is no animal research on Adamax. It's important not to substitute data on Semax (its supposed parent compound) as if it were evidence for Adamax — they are chemically different and have not been shown to behave the same way.
Source material
Use the linked publications and records to evaluate study design, population, limitations, and relevance.